Intellia Therapeutics (NTLA) EBITDA Margin Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3,609.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,536.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -957.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 8,807.00 |
| 10 | Intellia Therapeutics | 1.63 Bn | 1.63 Bn | - | 3,695.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,695.00 |
| Dec 31, 2025 | 60,617.00 |
| Sep 30, 2025 | 70,793.00 |
| Jun 30, 2025 | 140,196.00 |
| Mar 31, 2025 | -31,075.00 |
| Dec 31, 2024 | -784,775.00 |
| Sep 30, 2024 | -42,393.00 |
| Jun 30, 2024 | -119,704.00 |
| Mar 31, 2024 | 40,599.00 |
| Dec 31, 2023 | 764,710.00 |
| Sep 30, 2023 | -16,462.00 |
| Jun 30, 2023 | -19,035.00 |
| Mar 31, 2023 | 57,343.00 |
| Dec 31, 2022 | -17,036.00 |
| Sep 30, 2022 | 2.31 Mn |
| Jun 30, 2022 | 32,226.00 |
| Mar 31, 2022 | -63,644.00 |
| Dec 31, 2021 | -1,091.00 |
| Sep 30, 2021 | -2.38 Mn |
| Jun 30, 2021 | -84,997.00 |
| Mar 31, 2021 | -8,323.00 |
| Dec 31, 2020 | -38,097.00 |
| Sep 30, 2020 | 9,601.00 |
| Jun 30, 2020 | 2,872.00 |
| Mar 31, 2020 | -42,442.00 |
| Dec 31, 2019 | -1,694.00 |
| Sep 30, 2019 | 8,459.00 |
| Jun 30, 2019 | 6,018.00 |
| Mar 31, 2019 | 7,647.00 |
| Dec 31, 2018 | 12,834.00 |
| Sep 30, 2018 | -8,949.00 |
| Jun 30, 2018 | -1,873.00 |
| Mar 31, 2018 | -7,759.00 |
| Dec 31, 2017 | -17,833.00 |
| Sep 30, 2017 | -5,888.00 |
| Jun 30, 2017 | -10,555.00 |
| Mar 31, 2017 | 16,837.00 |
| Dec 31, 2016 | 13,201.00 |
| Sep 30, 2016 | 3,748.00 |
| Jun 30, 2016 | 8,337.00 |
| Mar 31, 2016 | -28,378.00 |